Tom Crabbe

783 total citations
13 papers, 632 citations indexed

About

Tom Crabbe is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tom Crabbe has authored 13 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tom Crabbe's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Tom Crabbe is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Tom Crabbe collaborates with scholars based in United Kingdom, United States and Netherlands. Tom Crabbe's co-authors include James P. O’Connell, Andrew Docherty, Gillian Murphy, Sarojani Angal, Stephen G. Ward, Melanie J. Welham, Phillip T. Hawkins, Laura Milne, Suhasini Kulkarni and Takehiko Sasaki and has published in prestigious journals such as Nature Cell Biology, Journal of Molecular Biology and Trends in Biochemical Sciences.

In The Last Decade

Tom Crabbe

13 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Crabbe United Kingdom 10 305 179 160 153 93 13 632
A. Yu. Baryshnikov Russia 16 445 1.5× 90 0.5× 186 1.2× 133 0.9× 41 0.4× 79 704
Aleksandra Simiczyjew Poland 16 295 1.0× 124 0.7× 213 1.3× 101 0.7× 115 1.2× 29 555
Laura A. Rudolph‐Owen United States 10 763 2.5× 126 0.7× 361 2.3× 336 2.2× 81 0.9× 12 1.2k
Stephen I. Rudnick United States 9 391 1.3× 165 0.9× 270 1.7× 52 0.3× 89 1.0× 11 798
Astrid Clarke United States 11 715 2.3× 234 1.3× 171 1.1× 46 0.3× 141 1.5× 27 1000
Sabita Sankar United States 10 534 1.8× 83 0.5× 152 0.9× 155 1.0× 43 0.5× 15 668
Erica Wilson United Kingdom 13 318 1.0× 249 1.4× 159 1.0× 73 0.5× 76 0.8× 19 729
T Yoneda Japan 8 453 1.5× 185 1.0× 123 0.8× 51 0.3× 88 0.9× 17 682
Georgina P. Coló Argentina 16 406 1.3× 114 0.6× 189 1.2× 120 0.8× 213 2.3× 24 761
Dejan Caglič Slovenia 10 245 0.8× 40 0.2× 132 0.8× 215 1.4× 65 0.7× 16 537

Countries citing papers authored by Tom Crabbe

Since Specialization
Citations

This map shows the geographic impact of Tom Crabbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Crabbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Crabbe more than expected).

Fields of papers citing papers by Tom Crabbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Crabbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Crabbe. The network helps show where Tom Crabbe may publish in the future.

Co-authorship network of co-authors of Tom Crabbe

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Crabbe. A scholar is included among the top collaborators of Tom Crabbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Crabbe. Tom Crabbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Price, Rebecca, Anthony Scott-Tucker, Jeffrey C. Kennedy, et al.. (2024). Enhanced stabilisation and reduced fibril forming potential of an amyloidogenic light chain using a variable heavy domain to mimic the homodimer complex. FEBS Journal. 291(22). 4913–4929. 1 indexed citations
2.
Leysen, S., Rebecca J. Burnley, Elizabeth Rodríguez, et al.. (2021). A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1. Journal of Molecular Biology. 433(19). 167174–167174. 8 indexed citations
3.
Leysen, S., et al.. (2021). The identification and structural analysis of potential 14-3-3 interaction sites on the bone regulator protein Schnurri-3. Acta Crystallographica Section F Structural Biology Communications. 77(8). 254–261. 1 indexed citations
4.
Scott-Tucker, Anthony, et al.. (2020). Exploiting Single Domain Antibodies as Regulatory Parts to Modulate Monoterpenoid Production in E. coli. ACS Synthetic Biology. 9(10). 2828–2839. 10 indexed citations
5.
Alexander, Rikki, Mark Batchelor, Tom Crabbe, et al.. (2008). 4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase. Bioorganic & Medicinal Chemistry Letters. 18(15). 4316–4320. 35 indexed citations
6.
Perry, Benjamin, Gavin Bennett, George M. Buckley, et al.. (2008). Optimization of a series of multi-isoform PI3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5299–5302. 9 indexed citations
7.
Johnson, Andrew M., Mara Fortunato, Adam Platt, et al.. (2008). Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists. Journal of Leukocyte Biology. 84(4). 1202–1212. 34 indexed citations
8.
Crabbe, Tom, Melanie J. Welham, & Stephen G. Ward. (2007). The PI3K inhibitor arsenal: choose your weapon!. Trends in Biochemical Sciences. 32(10). 450–456. 67 indexed citations
9.
Ferguson, Gail, Laura Milne, Suhasini Kulkarni, et al.. (2006). PI(3)Kγ has an important context-dependent role in neutrophil chemokinesis. Nature Cell Biology. 9(1). 86–91. 212 indexed citations
10.
Skipp, Paul, et al.. (2003). Investigation of the kinetics and order of tyrosine phosphorylation in the T‐cell receptor ζ chain by the protein tyrosine kinase Lck. European Journal of Biochemistry. 270(11). 2369–2376. 29 indexed citations
11.
Crabbe, Tom, et al.. (2003). Proteases as drug targets. Biochemical Society Symposia. 70(70). 147–161. 32 indexed citations
12.
Owens, Raymond J., et al.. (1997). Molecular Cloning and Expression of a Human Phosphodiesterase 4C. Cellular Signalling. 9(8). 575–585. 26 indexed citations
13.
Docherty, Andrew, James P. O’Connell, Tom Crabbe, Sarojani Angal, & Gillian Murphy. (1992). The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends in biotechnology. 10(6). 200–207. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026